Cell-based therapy approaches: the hope for incurable diseases E Buzhor, L Leshansky, J Blumenthal, H Barash, D Warshawsky, Y Mazor, ... Regenerative medicine 9 (5), 649-672, 2014 | 214 | 2014 |
The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth N Kertesz, V Krasnoperov, R Reddy, L Leshanski, SR Kumar, S Zozulya, ... Blood 107 (6), 2330-2338, 2006 | 212 | 2006 |
LifeMap Discovery™: the embryonic development, stem cells, and regenerative medicine research portal R Edgar, Y Mazor, A Rinon, J Blumenthal, Y Golan, E Buzhor, I Livnat, ... PloS one 8 (7), e66629, 2013 | 117 | 2013 |
Human mesenchymal stem cells shift CD8+ T cells towards a suppressive phenotype by inducing tolerogenic monocytes I Hof-Nahor, L Leshansky, S Shivtiel, L Eldor, D Aberdam, J Itskovitz-Eldor, ... Journal of Cell Science 125 (19), 4640-4650, 2012 | 63 | 2012 |
Repair of full-thickness tendon injury using connective tissue progenitors efficiently derived from human embryonic stem cells and fetal tissues S Cohen, L Leshansky, E Zussman, M Burman, S Srouji, E Livne, ... Tissue Engineering Part A 16 (10), 3119-3137, 2010 | 63 | 2010 |
NF-κB DNA-binding activity in embryos responding to a teratogen, cyclophosphamide A Torchinsky, L Lishanski, O Wolstein, J Shepshelovich, H Orenstein, ... BMC Developmental Biology 2, 1-11, 2002 | 44 | 2002 |
Tissue engineering using human embryonic stem cells S Cohen, L Leshanski, J Itskovitz‐Eldor Methods in enzymology 420, 303-315, 2006 | 30 | 2006 |
Maternal mosaicism for a second mutational event—a novel deletion—in a familial adenomatous polyposis family harboring a new germ‐line mutation in the alternatively spliced … S Davidson, L Leshanski, G Rennert, S Eidelman, D Amikam Human mutation 19 (1), 83-84, 2002 | 20 | 2002 |
A Novel Case of a CAT to AAT Transversion in Codon 179 of the p53 Gene in a Supratentorial Primitive Neuroectodermal Tumor Harbored by a Young GirlCase Report and Review of the … S Postovsky, MW Ben Arush, R Elhasid, S Davidson, L Leshanski, ... Oncology 65 (1), 46-51, 2003 | 9 | 2003 |
Stent for restenosis prevention M Shoham, A Reches, L Leshansky, M Groskop, S Millis, Y Pentanovich US Patent 9,510,959, 2016 | 6 | 2016 |
Human embryonic stem cells prevent T-cell activation by suppressing dendritic cells function via TGF-beta signaling pathway L Leshansky, D Aberdam, J Itskovitz-Eldor, S Berrih-Aknin Stem cells 32 (12), 3137-3149, 2014 | 3 | 2014 |
A novel MLH1 mutation harbored as a germ line aberration by a young woman of an HNPCC-like family and exhibited by a CML patient when occurring prior to the initiation of the … D Amikam, L Leshanski, M Sagi International journal of molecular medicine 17 (6), 1023-1026, 2006 | 2 | 2006 |
Stent for restenosis prevention M Groskop, L LESHANSKY, S MILLIS, Y PENTANOVICH, A Reches, ... WO Patent App. PCT/IL2012/000,133, 2012 | | 2012 |
Immunomodulatory Properties of Human Embryonic Stem Cell: Mechanisms of Action and Use in Transplantation L Leshansky Technion-Israel Institute of Technology, Faculty of Medicine, 2012 | | 2012 |
70 Human embryonic stem cell-derived connective tissue progenitors for tissue engineering S Cohen, L Leshansky, E Zussman, J Itskovitz-Eldor Bone 3 (38), 34, 2006 | | 2006 |
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY-The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits … N Kertesz, V Krasnoperov, R Reddy, L Leshanski, SR Kumar, S Zozulya, ... Blood 107 (6), 2330-2338, 2006 | | 2006 |